117 related articles for article (PubMed ID: 7760978)
1. Evidence for differential modulation of mu-opioid receptor-mediated antinociceptive and antitussive activities by spleen-derived factor(s) from diabetic mice.
Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
Neuropharmacology; 1994 Dec; 33(12):1553-8. PubMed ID: 7760978
[TBL] [Abstract][Full Text] [Related]
2. The effect of chronic treatment with naltrindole, a selective delta-opioid antagonist, on mu-opioid receptor-mediated antinociception in diabetic mice.
Kamei J; Kawashima N; Iwamoto Y; Suzuki T; Nagase H; Misawa M; Kasuya Y
Psychopharmacology (Berl); 1993; 113(2):167-71. PubMed ID: 7855177
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of mu-opioid receptor-mediated antitussive activity by delta-opioid receptor agonists in mice.
Kamei J; Iwamoto Y; Suzuki T; Nagase H; Misawa M; Kasuya Y
Eur J Pharmacol; 1993 Mar; 234(1):117-20. PubMed ID: 8386091
[TBL] [Abstract][Full Text] [Related]
4. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
5. Modulation of mu-mediated antitussive activity in rats by a delta agonist.
Kamei J; Tanihara H; Kasuya Y
Eur J Pharmacol; 1991 Oct; 203(1):153-6. PubMed ID: 1665789
[TBL] [Abstract][Full Text] [Related]
6. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
Mattia A; Vanderah T; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Aug; 258(2):583-7. PubMed ID: 1650835
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of mu 2-mediated mechanisms in mu-mediated antitussive activity in the mouse.
Kamei J; Iwamoto Y; Kawashima N; Suzuki T; Nagase H; Misawa M; Kasuya Y
Neurosci Lett; 1993 Jan; 149(2):169-72. PubMed ID: 8386345
[TBL] [Abstract][Full Text] [Related]
8. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
[TBL] [Abstract][Full Text] [Related]
9. Effects of mu and delta opioid agonists and antagonists on affective vocal and reflexive pain responses during social stress in rats.
Vivian JA; Miczek KA
Psychopharmacology (Berl); 1998 Oct; 139(4):364-75. PubMed ID: 9809857
[TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of central antitussives].
Kamei J
Nihon Yakurigaku Zasshi; 1998 Jun; 111(6):345-55. PubMed ID: 9720082
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
12. Evidence for an involvement of the mu-type of opioid receptor in the modulation of learning.
Aloyo VJ; Romano AG; Harvey JA
Neuroscience; 1993 Jul; 55(2):511-9. PubMed ID: 8397346
[TBL] [Abstract][Full Text] [Related]
13. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
Mattia A; Farmer SC; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Bowen WD; Porreca F
J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737
[TBL] [Abstract][Full Text] [Related]
14. 7-Benzylidenenaltrexone (BNTX): a selective delta 1 opioid receptor antagonist in the mouse spinal cord.
Sofuoglu M; Portoghese PS; Takemori AE
Life Sci; 1993; 52(8):769-75. PubMed ID: 8383271
[TBL] [Abstract][Full Text] [Related]
15. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice.
Suh HH; Tseng LF
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):67-71. PubMed ID: 1976234
[TBL] [Abstract][Full Text] [Related]
16. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.
Suh HH; Tseng LF
Pharmacol Biochem Behav; 1990 Apr; 35(4):807-13. PubMed ID: 2161107
[TBL] [Abstract][Full Text] [Related]
17. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
[TBL] [Abstract][Full Text] [Related]
18. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
Qi JA; Bowen WD; Mosberg HI; Rothman RB; Porreca F
J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752
[TBL] [Abstract][Full Text] [Related]
19. Involvement of delta- and mu-opioid receptors in the potentiation of brain-stimulation reward.
Duvauchelle CL; Fleming SM; Kornetsky C
Eur J Pharmacol; 1996 Dec; 316(2-3):137-43. PubMed ID: 8982679
[TBL] [Abstract][Full Text] [Related]
20. Role of spleen or spleen products in the reduced locomotor-enhancing effect of morphine in diabetic mice.
Kamei J; Saitoh A
Neurosci Lett; 1996 May; 210(1):57-60. PubMed ID: 8762191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
